anal GLIDE

Manufacturer
Product Max Group Inc
Effective date
2016-08-08
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:46:43

Label at a glance#

Productanal GLIDE
Active ingredientBENZOCAINE
Label structure9 sections

Indications and uses

For temporary relief of pain or soreness in the perianal area.

Dosage and administration

When practical, cleanse the affected area with mild soap and warm water and rinse thoroughly. Gently dry by patting or blotting with toilet tissue or a soft cloth before application of this product. Apply to the affected area up to 6 times daily.

Label contents#

Full prescribing information#

Drug FactsActive Ingredient

OTC - ACTIVE INGREDIENT SECTION

Benzocaine 5%

Purpose

OTC - PURPOSE SECTION

Topical Analgesic

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

If swallowed get medical help or contact a Poison Control Center right away.

Uses

INDICATIONS & USAGE SECTION

  • For temporary relief of pain or soreness in the perianal area.

Warnings

WARNINGS SECTION

For external use only.

  • Avoid contact with eyes.
  • Certain persons can develop allergic reactions from ingredients in this product. If the symptom being treated goes not subside or if redness, irritation, swelling, pain or other symptoms develop or increase, discontinue use and consult a doctor.

Directions

DOSAGE & ADMINISTRATION SECTION

  • When practical, cleanse the affected area with mild soap and warm water and rinse thoroughly.
  • Gently dry by patting or blotting with toilet tissue or a soft cloth before application of this product.
  • Apply to the affected area up to 6 times daily.

Other Information

OTHER SAFETY INFORMATION

Do not use if safety seal is broken or missing.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Hydroxyethylcellulose, Methylparaben, PEG-8, Propylene Glycol, Propylparaben, Water

anal GLIDE EXTRA product label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

anal GLIDE EXTRA

Desensitizer Lubricating Gel

PREMIUM

Benzocaine Anorectal Gel

Anal Desensitizer

2 FL OZ (60 ml)

www.bodyactionproducts.com

Distributed by:

Body Action Products

Lutz, FL 33559

ACTION BODY PRODUCTS

PMG anal GlidePMG anal Glide

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
BENZOCAINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70742-092-012020-01-31C16284748780-19d75b9cf-f4c1-f424-e053-dadaa90a57ceanal GLIDE - 092

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70742-092-01anal GLIDE60 mL in 1 BOTTLE, PUMPGEL601

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70742-092ANAL GLIDE (BENZOCAINE) GEL [PRODUCT MAX GROUP INC]1Legacy NDC, 1 package rows20160808_55ac41c4-c0ff-4846-9a6f-39aedbe7d545.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
70742-09270742-092-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
bd0dd8a9-3d50-4b11-bed0-28e5efc99fb755ac41c4-c0ff-4846-9a6f-39aedbe7d5452016-08-08WarningsExact identifier
spl id: bd0dd8a9-3d50-4b11-bed0-28e5efc99fb7
spl set id: 55ac41c4-c0ff-4846-9a6f-39aedbe7d545

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.